永安药业：子公司永安康健深耕于大健康产业，将持续加大对自有品牌业务投入

Core Viewpoint - Yong'an Pharmaceutical is focusing on the dual development model of "contract manufacturing services" and "self-owned brand operations" through its subsidiary Yong'an Health, aiming to enhance market recognition and sustainable development capabilities in the health industry [1] Group 1: Business Development - Yong'an Health has been actively expanding its online and offline channels for its brand "Yijiani," which is positioned in the anti-fatigue functional solid beverage segment [1] - The company plans to increase investment in its self-owned brand business while continuing to develop its contract manufacturing services [1] Group 2: Financial Performance - In the first half of 2025, Yong'an Pharmaceutical reported revenue of approximately 367 million yuan, a year-on-year decrease of 13.72% [1] - The net profit attributable to the parent company was approximately 12.5 million yuan, reflecting a significant year-on-year decline of 76.19% [1] Group 3: Management Update - On September 3, Yong'an Pharmaceutical announced that the chairman, Chen Yong, has had the detention measures lifted by the Hekou County Supervisory Committee, allowing him to resume his duties [2] - The company's production and operational status remains normal following this development [2]